Arctoris contributes its capabilities and expertise to the fight against COVID-19
Establishing a broad range of remotely accessible COVID-19 assays including biochemical profiling for COVID-19 drug targets
Establishing a broad range of remotely accessible COVID-19 assays including biochemical profiling for COVID-19 drug targets
Paper published in npj Genomic Medicine demonstrates identification of more reportable CNVs with CytoSure v3 vs traditional array design
Promega automated sample preparation solution added to CDC COVID-19 test protocol
The test is intended to expand availability of COVID-19 screening resources in central Ohio
Join us on Wednesday, August 5, to learn how in vitro models can enable a deeper understanding of T cell biology
Watch this on-demand webinar to learn how to enhance sample preparation for a range of complex microbiome samples
xMAP SARS-CoV-2 Multi-Antigen IgG Assay is enabled by xMAP Technology, the gold standard for multiplexing serologic testing
Cambridge researchers have shown how rapid genome sequencing of virus samples and enhanced testing of hospital staff can help to identify clusters of healthcare-associated COVID-19 infections
Whole-genome sequencing offers the ability to reduce pediatric diagnostic odysseys which cost at least $14 billion annually in the U.S.
Faster, more accurate diagnoses are critical with non-small cell lung cancer, which accounts for about 85 percent of all lung cancer cases
Partnership awarded Innovate UK Knowledge Transfer Partnership grant
Capture higher quality multicolor images more quickly and achieve better quantitative results over the full field of view
The bridging assay aims to allow a full-length trimeric Spike protein from the COVID-19 virus to be used as both a capture and detection tool
The agreement allows First Genetics to bring its F-Genetics NGS system and in vitro diagnostic assays for reproductive health testing to Russian labs
The partnership aims to bring access to Twist's proprietary phage display libraries for the discovery of antibodies in Takeda's biologics pipeline
This recognition occurred at the 2020 NACCHO Annual Conference virtually July 7-9, 2020